InsiderTrades

Form 4 for STRO SUTRO BIOPHARMA, INC.

Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0002063633-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-03 2026-03-01+ STRO Pauling David GC, Chief Admin. Ofcr F - Tax $20.52 -1,521 7,964 -16% -$31.2K
DM 2026-03-03 2026-03-01+ STRO Pauling David GC, Chief Admin. Ofcr M - OptEx $0.00 +3,698 10.3K +56% $0
DM 2026-03-03 2026-03-01+ STRO Pauling David GC, Chief Admin. Ofcr M - OptEx $0.00 -3,698 500 -88% $0
DM 2026-03-03 2026-03-02 STRO Pauling David GC, Chief Admin. Ofcr A - Grant $0.00 +37.8K 4,200 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-02 F D 970 $20.55 9,350 D — — (F1) Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs; does not represent a sale by the reporting person.
2 Common Common Stock 2026-03-01 M A 500 $0.00 7,673 D — —
3 Common Common Stock 2026-03-01 M A 842 $0.00 8,515 D — —
4 Common Common Stock 2026-03-01 F D 551 $20.47 7,964 D — — (F1) Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs; does not represent a sale by the reporting person.
5 Common Common Stock 2026-03-02 M A 2,356 $0.00 10,320 D — —
6 Derivative Restricted Stock Units (RSUs) 2026-03-01 M D 842 $0.00 1,686 D — · — to 2028-03-01 842 Common Stock (F2) Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F4) The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2025, subject to continued service through each vesting date.
7 Derivative Restricted Stock Units (RSUs) 2026-03-02 M D 2,356 $0.00 7,069 D — · — to 2029-03-02 2,356 Common Stock (F2) Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F5) The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 2, 2026, subject to continued service through each vesting date.
8 Derivative Restricted Stock Units (RSUs) 2026-03-01 M D 500 $0.00 500 D — · — to 2027-03-01 500 Common Stock (F2) Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F3) The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2024, subject to continued service through each vesting date.
9 Derivative Stock Option (right to buy) 2026-03-02 A A 33,600 $0.00 33,600 D $20.55 · — to 2036-03-02 33,600 Common Stock (F7) 1/48 of the total option award shall vest monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on April 1, 2026.
10 Derivative Restricted Stock Units (RSUs) 2026-03-02 A A 4,200 $0.00 4,200 D — · — to 2030-03-01 4,200 Common Stock (F2) Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. (F6) The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date.